CD160: a unique activating NK cell receptor. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Immunology Letters Année : 2011

CD160: a unique activating NK cell receptor.

Résumé

Here we discuss CD160 an essential NK cell activating receptor that remains poorly understood. CD160 receptor exhibits a number of unique structural and functional characteristics that are not common to other killer immunoglobulin-like receptors that recognize major histocompatibility complex (MHC) class I molecules: (1) In addition to humans and mice, the cd160 gene is conserved in several other mammal species; (2) cd160 is located outside the NK gene complex and the Leukocyte Receptor Complex in humans; (3) CD160 expression is associated to the CD56(dim) CD16+ cytotoxic NK cell phenotype; (4) both human and mouse CD160 recognize MHC class Ia and Ib molecules; (5) unlike the other MHC class I-dependent activating NK receptors, CD160 is a glycosylphosphatidylinositol-anchored molecule with a single immunoglobulin-like domain, and does not bear immunoreceptor tyrosine-based activation motifs. Consequently, CD160 cannot signal by itself, requiring the recruitment of adaptor proteins. CD160 recruits phosphoinositide-3 kinase to trigger cytotoxicity and cytokine secretion; (6) specific engagement of NK CD160 receptor expressed by circulating NK cells produces proinflammatory cytokines IFN-γ, TNF-α, and, most notably, IL-6 and IL-8 as well as MIP1-β chemokine. The level of CD160-mediated IFN-γ production is always higher than the one observed after engagement of the CD16 receptor.

Domaines

Cancer

Dates et versions

hal-00640923 , version 1 (14-11-2011)

Identifiants

Citer

Philippe Le Bouteiller, Julie Tabiasco, Beata Polgar, Noemi Kozma, Jérôme Giustiniani, et al.. CD160: a unique activating NK cell receptor.. Immunology Letters, 2011, 138 (2), pp.93-6. ⟨10.1016/j.imlet.2011.02.003⟩. ⟨hal-00640923⟩
94 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More